Atlas Trials

A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects

Clinical trial NCT01235741 · TERMINATED

Trial details

NCT number
NCT01235741
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Obesity
Start date
2011-01-01
Primary completion
2011-09-01
Enrollment
213

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.